PCSK9 and pachyonychia congenita: The mCRPC CWR-R1ca cell line was chosen for this study since it represents one of the most highly aggressive and metastatic type II ADI PC phenotypes and has a highly dysregulated PCSK9-LDLR ratio (Figure 1A).